Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Institut Claudius Regaud
Takeda
Travera Inc
AstraZeneca
National Institutes of Health Clinical Center (CC)
Sorlandet Hospital HF
Adichunchanagiri Institute of Medical Sciences, B G Nagara
Northwestern University
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Dragonfly Therapeutics
Centre Oscar Lambret
Dana-Farber Cancer Institute
Sun Yat-sen University
Dana-Farber Cancer Institute
Sun Yat-sen University
NeoImmuneTech
University of Michigan Rogel Cancer Center
Rutgers, The State University of New Jersey
Rush University Medical Center
Zhejiang Cancer Hospital
Institute of Oncology Ljubljana
ARCAGY/ GINECO GROUP
University of Tennessee Graduate School of Medicine
University of Alabama at Birmingham
University of Iowa
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
Cedars-Sinai Medical Center
Institut Bergonié
Royal Marsden NHS Foundation Trust
University Hospital, Ghent
Impact Therapeutics, Inc.
SN BioScience
Cue Biopharma
Lumicell, Inc.
Abramson Cancer Center at Penn Medicine
AbbVie
National Institutes of Health Clinical Center (CC)
Shattuck Labs, Inc.
Risen (Suzhou) Pharma Tech Co., Ltd.
University Hospital, Tours
Hospices Civils de Lyon
Hospices Civils de Lyon
University of Exeter
Memorial Sloan Kettering Cancer Center
I-Mab Biopharma US Limited
SpringWorks Therapeutics, Inc.
Seagen Inc.